John Wojcik
Executive Director, Head Translational Molecular Biomarkers, Merck
Graduation year:
2010
Thesis:
The Development of Highly Selective Monobody Inhibitors of Human SH2 Domains
Advisor:
Shohei Koide, Stephen Meredith